Dr. Reddy's Laboratories ... (RDY)
15.18
-0.08 (-0.52%)
At close: Jan 15, 2025, 10:18 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 |
| Net Income | 55.68B | 60.48B | 23.57B | 19.15B | 19.50B | 18.80B | 9.81B | 12.04B | 20.01B | 22.18B | 21.51B | 16.78B | 14.26B | 11.04B | 1.07B | -5.17B | 4.68B | 9.35B | 1.63B | 211.27M | 2.48B | 3.52B | 4.92B | 739.28M |
| Depreciation & Amortization | 14.84B | 12.50B | 11.82B | 12.80B | 12.47B | 12.19B | 11.71B | 11.28B | 10.25B | 8.10B | 7.11B | 5.55B | 5.21B | 4.15B | 4.16B | 3.81B | 6.20B | 3.02B | 1.57B | 1.31B | 1.13B | 1.01B | 945.26M | 892.60M |
| Stock-Based Compensation | 821.00M | 397.00M | 592.00M | 584.00M | 521.00M | 389.00M | 454.00M | 398.00M | 471.00M | 498.00M | 436.00M | 390.00M | 326.00M | 265.00M | 226.00M | 131.00M | 257.79M | 175.38M | 162.25M | 144.00M | 147.73B | n/a | n/a | n/a |
| Other Working Capital | 6.32B | -5.20B | -8.59B | 1.59B | -6.05B | 2.73B | -5.73B | 975.00M | 2.33B | -9.59B | -6.42B | -4.78B | 1.36B | 311.00M | -854.00M | 1.02B | -653.89M | -3.10B | -1.57B | 1.31B | -709.55B | -679.08B | -933.07M | -988.33M |
| Other Non-Cash Items | -21.92B | -21.96B | -2.69B | 2.29B | 6.35B | -547.00M | 488.00M | 535.00M | 3.57B | 3.31B | -4.30B | -1.15B | 1.10B | -2.11B | 8.33B | 12.82B | 592.61M | 3.46B | 214.37M | 609.41M | -147.37B | 494.31M | 352.83M | -46.56K |
| Deferred Income Tax | 16.19B | 15.30B | 8.73B | 9.18B | -1.47B | 3.65B | 4.54B | 2.61B | 7.13B | 5.98B | 5.09B | 4.90B | 4.20B | 1.40B | 985.00M | 1.17B | -2.35B | -1.11B | -55.30M | -95.59M | -135.14M | 568.72K | -268.29M | 19.46M |
| Change in Working Capital | -20.18B | -7.86B | -13.91B | -8.29B | -7.54B | -5.77B | -8.96B | -5.35B | -188.00M | -15.04B | -10.39B | -13.15B | -8.96B | -6.74B | -1.55B | -8.27B | -3.26B | -3.06B | -1.88B | 113.23M | 168.46M | -677.77M | -1.30B | -1.29B |
| Operating Cash Flow | 45.43B | 58.87B | 28.11B | 35.70B | 29.84B | 28.70B | 18.03B | 21.51B | 41.25B | 25.03B | 19.46B | 13.32B | 16.15B | 8.01B | 13.23B | 4.50B | 6.12B | 11.83B | 1.65B | 2.29B | 4.01B | 4.35B | 4.65B | 614.87M |
| Capital Expenditures | -27.43B | -18.86B | -19.05B | -12.56B | -6.12B | -7.49B | -11.04B | -40.98B | -14.88B | -15.33B | -10.63B | -7.34B | -8.59B | -11.61B | -4.28B | -4.76B | -6.77B | -4.75B | -1.92B | -1.75B | -2.42B | -1.51B | -1.09B | -487.20M |
| Acquisitions | -12.00M | n/a | -326.00M | -15.51B | 1.27B | 536.00M | 1.75B | -103.00M | -7.94B | -276.00M | 546.00M | -1.75B | 1.73B | -1.17B | -93.00M | -3.17B | 55.04M | 84.24M | -27.34B | -535.68M | -9.46M | -346.68M | 49.26M | n/a |
| Purchase of Investments | -145.49B | -136.17B | -88.97B | -75.42B | -111.92B | -78.57B | -68.43B | -49.65B | -68.25B | -53.47B | -44.81B | -27.88B | -26.31B | -8.96B | -24.11B | -12.39B | -15.86B | -490.47M | -5.09B | -10.23B | -13.27B | -2.93B | -2.45B | -275.17M |
| Sales Maturities Of Investments | 129.78B | 112.81B | 77.77B | 79.53B | 111.70B | 76.29B | 64.04B | 71.59B | 69.27B | 45.18B | 37.72B | 21.85B | 15.73B | 12.60B | 21.10B | 16.40B | 12.48B | 332.66M | 5.29B | 13.08B | 9.19B | 2.93B | 2.36B | n/a |
| Other Investing Acitivies | -8.16B | 859.00M | 4.19B | 1.30B | 137.00M | 1.51B | -1.20B | 672.00M | 1.37B | 989.00M | 551.00M | 1.17B | -1.23B | 475.00M | 387.00M | 456.00M | 496.68M | 5.42B | -5.56B | 64.72M | -6.16M | -97.16M | -404.48M | 75.43M |
| Investing Cash Flow | -40.28B | -41.37B | -26.39B | -22.66B | -4.92B | -7.73B | -14.88B | -18.47B | -20.42B | -22.90B | -16.62B | -13.94B | -18.66B | -8.66B | -7.00B | -3.47B | -9.60B | 593.86M | -34.61B | 632.88M | -6.52B | -1.95B | -1.53B | -686.95M |
| Debt Repayment | -1.15B | -1.01B | 2.73B | -697.00M | -19.16B | -15.18B | 882.00M | -5.22B | -11.98B | -3.72B | 3.96B | 2.29B | 7.05B | 8.68B | -3.56B | -1.79B | -7.14B | -7.78B | 27.99B | 2.36B | 166.33M | 38.15M | -3.80B | 46.65M |
| Common Stock Repurchased | n/a | n/a | n/a | -1.19B | -474.00M | -535.00M | n/a | -15.69B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -116.23M | n/a | n/a | n/a |
| Dividend Paid | -6.65B | -4.98B | -4.15B | -4.15B | -3.92B | -4.00B | -3.99B | -3.39B | -4.11B | -3.07B | -2.98B | -2.71B | -2.22B | -3.06B | -1.23B | -738.00M | -737.28M | -438.54M | -437.48M | -431.62M | -432.54M | -190.76M | -561.04M | -134.00M |
| Other Financial Acitivies | 3.23B | -21.23B | -1.34B | 5.47B | -2.21B | -1.61B | -1.33B | 20.61B | -1.61B | 3.19B | -1.19B | -1.37B | -1.11B | -6.02B | -529.00M | n/a | 287.00K | -79.23M | -341.10M | 0.08 | 43.38K | -152.87B | -48.73K | 0.84 |
| Financial Cash Flow | -3.76B | -26.86B | -2.42B | -298.00M | -25.16B | -21.33B | -4.44B | -3.69B | -17.00B | -4.12B | -217.00M | -1.79B | 3.73B | -377.00M | -5.31B | -2.53B | -6.83B | 1.76B | 27.28B | 1.93B | -376.92M | -152.56M | 1.42B | -87.35M |
| Net Cash Flow | 1.33B | -9.07B | 32.00M | 12.86B | -266.00M | -314.00M | -1.24B | -1.14B | -473.00M | -3.06B | 3.40B | -2.33B | 1.72B | -885.00M | 1.17B | -1.61B | -10.58B | 14.30B | -5.59B | 4.91B | -2.90B | 2.16B | 4.63B | -78.27M |
| Free Cash Flow | 18.00B | 40.01B | 9.06B | 23.14B | 23.73B | 21.21B | 6.99B | -19.47B | 26.37B | 9.71B | 8.84B | 5.98B | 7.57B | -3.60B | 8.94B | -256.00M | -646.96M | 7.08B | -272.35M | 542.45M | 1.59B | 2.84B | 3.56B | 127.67M |